Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-01-12Clinical Trial Update: Development of Therapeutic Intervention for Sleep in Alzheimer/Caregiver Dyads
A Yale University-sponsored clinical trial studying a sleep intervention for people with Alzheimer's disease and their caregivers has been w…
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 [Phase 2]
Phase 2 study evaluating safety and tolerability of multiple-dose regimens of CHF 5074 in Alzheimer's disease has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients [Phase 3]
A Phase 3 trial of bapineuzumab in Alzheimer's disease was terminated; results were posted January 8, 2016.
-
CLINICAL_TRIALS trial_result · 2016-01-06Clinical Trial Update: Clinical Trial of Donepezil Between the Naive Group and the Switching Group [NA]
This is a completed clinical trial comparing donepezil between naive and switching groups in Alzheimer's disease and dementia; specific resu…
-
CLINICAL_TRIALS trial_result · 2016-01-06Clinical Trial Update: Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia [NA]
Completed clinical trial evaluating donepezil in patients with Alzheimer's disease and mixed dementia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Coordinating Center for Caregiver Intervention Trial [NA]
The University of Pittsburgh–sponsored Coordinating Center for Caregiver Intervention Trial for dementia and Alzheimer's disease has complet…
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease [Phase 2]
Phase 2 clinical trial results for ACC-001 in Japanese patients with Alzheimer's disease focusing on safety, tolerability, and immunogenicit…
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease [Phase 2]
Pfizer's Phase 2 study of ACC-001 in mild to moderate Alzheimer's disease has completed, with results posted on 2016-01-01.
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease [Phase 2]
Pfizer's Phase 2 trial of ACC-001 in mild-to-moderate Alzheimer's disease completed, and results assessing safety, tolerability, and immunog…
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease [Phase 2]
Pfizer announced results from a Phase 2 trial of ACC-001 in Japanese patients with mild to moderate Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients [Phase 3]
This document summarizes the long-term safety and tolerability extension of bapineuzumab in patients with Alzheimer's disease in a Phase 3 p…
-
CLINICAL_TRIALS trial_result · 2015-12-21Clinical Trial Update: Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD [Phase 1]
This Phase 1 trial update reports observations of amyloid-related imaging abnormalities, including microbleeds, in participants with atypica…
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: Alzheimer Patients and the Snoezelen Program [Phase 1]
Phase 1 clinical trial update evaluating the Snoezelen multisensory program for dementia, including Alzheimer's disease. The study, sponsore…
-
CLINICAL_TRIALS trial_result · 2015-12-11Clinical Trial Update: A Longitudinal Multidimensional Population Study on Brain Aging
This entry reports the completion of a longitudinal population study on brain aging sponsored by Fondazione Golgi Cenci. It focuses on demen…
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease [Phase 2]
A Phase 2 study evaluating the combination of Dimebon and Donepezil for Alzheimer's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Gray Matters Alzheimer's Disease Prevention Intervention [NA]
The Gray Matters trial, an Alzheimer's disease prevention intervention sponsored by Utah State University, has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers [Phase 2, Phase 3]
This clinical trial evaluated caregiver skills training to improve mood and behavior among assisted living residents with dementia and Alzhe…
-
CLINICAL_TRIALS research · 2015-12-02Clinical Trial Update: Patients With Behavioural Symptoms and Hospitalized in Cognitive and Behavioural Units
A completed clinical trial involving patients with Alzheimer disease focusing on behavioral symptoms hospitalized in cognitive and behaviora…
-
FDA approval · 2015-12-01FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for donepezil hydrochloride submitted by ScieGen Pharmaceuticals, Inc., authorizing changes to t…
-
FDA label_change · 2015-11-30FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for donepezil hydrochloride filed by Rising Pharma Holdings, Inc., likely reflecting labeling ch…
-
FDA approval · 2015-11-30FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Ajanta Pharma USA Inc.)
FDA approved the original application for memantine hydrochloride from Ajanta Pharma USA Inc., allowing marketing of a generic memantine pro…
-
FDA approval · 2015-11-20FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for a generic donepezil hydrochloride product manufactured by Solco Healthcare US, LLC.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study [Phase 4]
Phase 4, controlled study evaluating methylphenidate for apathy in Alzheimer's disease. The results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT) [Phase 4]
Phase 4 study assessing low-dose opiate therapy to relieve discomfort in patients with Alzheimer's disease and other forms of dementia has c…
-
FDA approval · 2015-11-17FDA Approved: RIVASTIGMINE TARTRATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approves a supplemental application for rivastigmine tartrate submitted by Macleods Pharmaceuticals Limited.